Health Care & Pharma Webinar: Keeping Within Regulatory Guidelines While Exploring New Frontiers in Healthcare Social Media

WHEN: 3 pm EST Thursday, October 22

Registration is limited to WOMMA members and their appropriate brand clients.

Arnie Friede
Former Associate Chief Counsel at FDA

Mark Senak
Pharma & Biotech Strategist

Ann Moravick
EVP of Ketchum

REGISTER NOW

WOMMA is hosting a webinar review the top concerns of communicators relating to drug and device industry communications discuss how companies have addressed these concerns in social media platforms, discuss low-risk, creative social media strategies that companies are undertaking to increase communications impact and discuss the role of industry in advancing social media in healthcare and responsibilities of industry for being its own watchdog.

Additionally we’ll brief registrants about WOMMA’s efforts to respond to FDA’s recent hearings and comments requests.

REGISTER NOW

This webinar will feature two guest speakers including Arnie Friede, former Associate Chief Counsel at FDA and currently sole practioner for food and drug law in his own practice, Arnold I. Friede & Associates. Mark Senak, of WOMMA member company Fleishman-Hillard, is an authority on regulatory aspects of communications and medical products, with particular emphasis on pre-approval communications. Mark is also a strategist to help pharma and biotech companies prepare best case for advisory committee approval and deals with issues and crisis management. The panel will be moderated by Ann Moravick, former EVP of Ketchum and current founder and president of Rx4Good, a corporate social responsibility service that matches healthcare companies with evidence-based healthcare causes that are making a difference in healthcare.